The cannabinoid system and immune modulation

被引:400
作者
Klein, TW [1 ]
Newton, C [1 ]
Larsen, K [1 ]
Lu, L [1 ]
Perkins, I [1 ]
Nong, L [1 ]
Friedman, H [1 ]
机构
[1] Univ S Florida, Coll Med, Dept Med Microbiol & Immunol, Tampa, FL 33612 USA
关键词
marijuana; Th1; cells; chemotaxis; tumor; G protein; CB1; PROTEIN-COUPLED RECEPTORS; CANCER CELL-PROLIFERATION; MESSENGER-RNA EXPRESSION; MACROPHAGE-LIKE CELLS; CB2; RECEPTOR; ADENYLATE-CYCLASE; MOLECULAR CHARACTERIZATION; ENDOGENOUS CANNABINOIDS; LEGIONELLA-PNEUMOPHILA; NUCLEAR FACTOR;
D O I
10.1189/jlb.0303101
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Studies on the effects of marijuana smoking have evolved into the discovery and description of the endocannabinoid system. To date, this system is composed of two receptors, CB1 and CB2, and endogenous ligands including anandamide, 2-arachidonoyl glycerol, and others. CB1 receptors and ligands are found in the brain as well as immune and other peripheral tissues. Conversely, CB2 receptors and ligands are found primarily in the periphery, especially in immune cells. Cannabinoid receptors are G protein-coupled receptors, and they have been linked to signaling pathways and gene activities in common with this receptor family. In addition, cannabinoids have been shown to modulate a variety of immune cell functions in humans and animals and more recently, have been shown to modulate T helper cell development, chemotaxis, and tumor development. Many of these drug effects occur through cannabinoid receptor signaling mechanisms and the modulation of cytokines and other gene products. It appears the immunocannabinoid system is involved in regulating the brain-immune axis and might be exploited in future therapies for chronic diseases and immune deficiency.
引用
收藏
页码:486 / 496
页数:11
相关论文
共 121 条
[1]  
Adams IB, 1996, ADDICTION, V91, P1585, DOI 10.1111/j.1360-0443.1996.tb02264.x
[2]   Marijuana and cocaine impair alveolar macrophage function and cytokine production [J].
Baldwin, GC ;
Tashkin, DP ;
Buckley, DM ;
Park, AN ;
Dubinett, SM ;
Roth, MD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (05) :1606-1613
[3]   Neurobiology - How cannabinoids work in the brain [J].
Barinaga, M .
SCIENCE, 2001, 291 (5513) :2530-2531
[4]   ANTINOCICEPTIVE (AMINOALKYL)INDOLES [J].
BELL, MR ;
DAMBRA, TE ;
KUMAR, V ;
EISSENSTAT, MA ;
HERRMANN, JL ;
WETZEL, JR ;
ROSI, D ;
PHILION, RE ;
DAUM, SJ ;
HLASTA, DJ ;
KULLNIG, RK ;
ACKERMAN, JH ;
HAUBRICH, DR ;
LUTTINGER, DA ;
BAIZMAN, ER ;
MILLER, MS ;
WARD, SJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (03) :1099-1110
[5]   Cannabinoid receptors and the regulation of immune response [J].
Berdyshev, EV .
CHEMISTRY AND PHYSICS OF LIPIDS, 2000, 108 (1-2) :169-190
[6]   Inhibition of tumor angiogenesis by cannabinoids [J].
Blázquez, C ;
Casanova, ML ;
Planas, A ;
del Pulgar, TG ;
Villanueva, C ;
Fernández-Aceñero, MJ ;
Aragonés, J ;
Huffman, JW ;
Jorcano, JL ;
Guzmán, M .
FASEB JOURNAL, 2003, 17 (01) :529-+
[7]   CANNABINOID-RECEPTOR EXPRESSION IN HUMAN-LEUKOCYTES [J].
BOUABOULA, M ;
RINALDI, M ;
CARAYON, P ;
CARILLON, C ;
DELPECH, B ;
SHIRE, D ;
LEFUR, G ;
CASELLAS, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (01) :173-180
[8]   Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor - Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression [J].
Bouaboula, M ;
PoinotChazel, C ;
Marchand, J ;
Canat, X ;
Bourrie, B ;
RinaldiCarmona, M ;
Calandra, B ;
LeFur, G ;
Casellas, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 237 (03) :704-711
[9]   Regulation of interleukin-12 production by G-protein-coupled receptors [J].
Braun, MC ;
Kelsall, BL .
MICROBES AND INFECTION, 2001, 3 (02) :99-107
[10]   Cloning and molecular characterization of the rat CB2 cannabinoid receptor [J].
Brown, SM ;
Wager-Miller, J ;
Mackie, K .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2002, 1576 (03) :255-264